Effect of physical exercise on tumor growth regulating factors of tumor microenvironment: Implications in exercise-dependent tumor growth retardation

Immunopharmacology and Immunotoxicology

Volumn 31, Issue 2, 2009, Pages 274-282

  Verma, Vinod Kumar ^a   Singh, Vivek ^a   Singh, Mahendra Pal ^a   Singh, Sukh Mahendra ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Cytokines; Nitric oxide; T cell lymphoma; Treadmill exercise; Tumor growth retardation; Tumor microenvironment

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 4; LACTIC ACID; NITRIC OXIDE; OXYGEN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES FLUID; CONTROLLED STUDY; CYTOKINE PRODUCTION; ERYTHROCYTE COUNT; EXERCISE; INHIBITION KINETICS; MALE; MICROENVIRONMENT; MODULATION; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; IMMUNOLOGY; LYMPHOMA; NEOVASCULARIZATION, PATHOLOGIC; PERITONEUM; VASCULARIZATION;

MURINAE;

ANIMALS; ASCITIC FLUID; CYTOKINES; HYDROGEN-ION CONCENTRATION; LACTIC ACID; LYMPHOMA; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXYGEN; PERITONEUM; PHYSICAL CONDITIONING, ANIMAL; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 70350629085     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970802562042     Document Type: Article

References (56)

1. Ullrich, E; Ménard, C; Flament, C; Terme, M; Mignot, G; Bonmort, M; Plumas, J; Chaperot, L; Chaput, N; Zitvogel, L. Dendritic cells and innate defense against tumor cells. Cytokine Growth Factor Rev. 2008; 19(1),79-92.
2. Shafer-Weaver, K; Anderson, M; Malyguine, A; Hurwitz, AA. T cell tolerance to tumors and cancer immunotherapy. Adv Exp Med Biol. 2007; 601,357-368
3. Reed, JC. Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nat Clin Pract Oncol. 2006; 3(7),388-398
4. Peplonska, B; Lissowska, J; Hartman, TJ; Szeszenia-Dabrowska, N; Blair, A; Zatonski, W; Sherman, ME; Garcia-Closas, M; Brinton, LA. Adulthood lifetime physical activity and breast cancer. Epidemiology. 2008; 19(2),226-236
5. Rogers, CJ; Colbert, LH; Greiner, JW; Perkins, SN; Hursting, SD. Physical activity and cancer prevention: Pathways and targets for intervention. Sports Med. 2008; 38(4),271-296
6. Barnard, RJ; Leung, PS; Aronson, WJ; Cohen, P; Golding, LA. A mechanism to explain how regular exercise might reduce the risk for clinical prostate cancer. Eur J Cancer Prev. 2007; 16(5),415-421
7. Kizaki, T; Takemasa, T; Sakurai, T; Izawa, T; Hanawa, T; Kamiya, S; Haga, S; Imaizumi, K; Ohno, H. Adaptation of macrophages to exercise training improves innate immunity. Biochem Biophys Res Commun. 2008; 372(1),152-156
8. Rykova, MP; Antropova, EN; Popov, DV; Vinogradova, OL; Larina, IM. The activation processes of the immune system during low intensity exercise without relaxation. Ross Fiziol Zh Im I M Sechenova. 2008; 94(2),212-219
9. West, NP; Pyne, DB; Kyd, JM; Renshaw, GM; Fricker, PA; Cripps, AW. The effect of exercise on innate mucosal immunity. Br J Sports Med. 2008. [Epub ahead of print].
10. Suzuki, K; Tagami, K. Voluntary wheel-running exercise enhances antigen-specific antibody-producing splenic B cell response and prolongs IgG half-life in the blood. Eur J Appl Physiol. 2005; 94(5-6),514-519
11. Herr, I; Debatin, KM. Cellular stress response and apoptosis in cancer therapy. Blood. 2001; 98(9),2603-2614
12. Armitage, JO; Vose, JM; Weisenburger, DD. Towards understanding the peripheral T-cell lymphomas. Ann Oncol. 2004; 15(10),1447-1449
13. Massone, C; Chott, A; Metze, D; Kerl, K; Citarella, L; Vale, E; Kerl, H; Cerroni, L. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol. 2004; 28(6),719-735
14. Ben-Effrain, S. One hundred years of cancer immunotherapy: A critical appraisal. Tumor Biol. 1999; 20,1-24.
15. Singh, MP; Rai, AK; Singh, SM. Gender dimorphism in the progressive in vivo growth of a T cell lymphoma: involvement of cytokines and gonadal hormones. J Reprod Immunol. 2005; 65(1),17-32.
16. Kumar, A; Singh, SM. Effect of tumor growth on the blastogenic response of splenocytes: A role of macrophage-derived nitric oxide. Nat Immun. 1998; 16(5-6),215-227
17. Bharti, AC; Singh, SM. Inhibition of macrophage nitric oxide production by gangliosides derived from a spontaneous T cell lymphoma: The involved mechanisms. Nitric Oxide. 2003; 8(1),75-82.
18. Singh, MP; Sharma, H; Singh, SM. Prolactin promotes growth of a spontaneous T cell lymphoma: Role of tumor and host derived cytokines. Cancer Invest. 2006; 24(6),601-610
19. Singh, MP; Singh, G; Singh, SM. Paraneoplastic neurodegeneration in a murine host following progressive growth of a spontaneous T-cell lymphoma: Role of proinflammatory internal responses. Neuroimmunomodulation. 2006; 13(2),122-132
20. Parajuli, P; Singh, SM; Kumar, A. Effect of cisplatin and FK565 on the activation of tumor-associated and bone marrow-derived macrophages by Dalton's lymphoma. Int J Immunopharmacol. 1995; 17(1),1-7.
21. Gupta, V; Singh, SM. Gender dimorphism in the myeloid differentiation of bone marrow precursor cells in a murine host bearing a T cell lymphoma. J Reprod Immunol. 2007; 74(1-2),90-102.
22. Gupta, V; Singh, SM. Gender dimorphism of tumor growth: role of gonadal hormones in differential regulation of apoptosis of a murine T cell lymphoma. J Biomed Sci. 2008; 15(2),147-162
23. Gupta, V; Singh, SM. Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma. Anticancer Drugs. 2008; 19(6),583-592
24. Gupta, V; Singh, SM. Gender dimorphism of macrophage response to GMCSF and IL-4 for differentiation into dendritic cells. Am J Reprod Immunol. 2008; 60(1),43-54.
25. Singh, MP; Singh, G; Singh, SM. Role of host's antitumor immunity in exercise-dependent regression of murine T-cell lymphoma. Comp Immunol Microbiol Infect Dis. 2005; 28(3),231-248
26. Singh, V; Singh, SM. Cell density-dependent alterations in tumorigenic potential of a murine T-cell lymphoma: implication in the evolution of multidrug resistance in tumor cells. Anticancer Drugs. 2008; 19(8),793-804.
27. Singh, V; Singh, SM. Effect of high cell density on the growth properties of tumor cells, a role in tumor cytotoxicity of chemotherapeutic drugs. Anticancer Drugs. 2007; 18(10):1123-1132
28. Su, SH; Chen, HI; Jen, CJ. Severe exercise enhances phagocytosis by murine bronchoalveolar macrophages. J Leukoc Biol. 2001; 69(1),75-80.
29. Kohut, ML; Boehm, GW; Moynihban, JA. Moderate exercise is associated with enhanced antigen-specific cytokine, but not IgM antibody production in aged mice. Mech Aging Dev. 2001; 122,1135-1150
30. Bradford, MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72,248-254
31. Davis, BJ. Disc electrophoresis II. Method and application to human serum proteins. Ann N Y Acad Sci. 1964; 121,404-427
32. Ding, AH; Nathan, CF; Stuehr, DJ. Release of reactive nitrogen intermediates and oxygen intermediates from murine peritoneal macrophages: Comparison of the activation cytokines and independent production. J Immunol. 1988; 141,2407-2412
33. Sakai, TS; Piao, N; Teshima, N; Kuroishi, T; Grudpan, K. Flow injection system with in-line WINKLER'S procedure using 16-way valve and spectrofluorimetric determination of dissolved oxygen in environmental waters et al. Talanta. 2004; 63,893-898.
34. Somoza, B; Guzmán, R. Induction of Cardiac Uncoupling protein- 2 expression and adenosine 5'-monophosphate-activated protein kinase phosphorylation during early states of diet- induced obesity in mice. Endocrinology. 2006; 148,924-931
35. Singh, MP; Singh, SM. Role of host's antitumor immunity in exercise dependent regression of murine T cell lymphoma. Comp Immunol Microbiol Infect Dis. 2005; 28,231-248
36. Bamias, A; Koutsoukou, V; Terpos, E; Tsiatas, ML; Liakos, C; Tsitsilonis, O; Rodolakis, A; Voulgaris, Z; Vlahos, G; Papageorgiou, T; Papatheodoridis, G; Archimandritis, A; Antsaklis, A; Dimopoulos, MA. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy. Gynecol Oncol. 2008; 108(2),421-427
37. Korsisaari, N; Ross, J; Wu, X; Kowanetz, M; Pal, N; Hall, L; Eastham-Anderson, J; Forrest, WF; Van, Bruggen; Peale, N; , FV; Ferrara, N. Blocking vascular endothelial growth factor-a inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1. Clin Cancer Res. 2008; 14,249-258
38. Ewan, KB; Henshall-Powell, RL; Ravani, SA; Pajares, MJ; Arteaga, C; Warters, R; Akhurst, RJ; Barcellos-Hoff, MH. Transforming growth factor-ß1 mediates cellular response to DNA damage in situ. Cancer Res. 2002; 62,5627-5631
39. Folkman, J. Angiogenesis: An organizing principle for drug discovery? Nat Rev Drug Discov. 2007; 6,273-286 (Pubitemid 46505878)
40. Shubjeet, Kaur; Joaquin, Cortiella; Charles, A. Vacanti. Identifying a site for maximum delivery of oxygen to transplanted cells. Tissue Eng. 2000, 6,229-232.
41. Koga, S; Poole, DC; Ferreira, LF; Whipp, BJ; Kondo, N; Saitoh, T; Ohmae, E; Barstow, TJ. Spatial heterogeneity of quadriceps muscle deoxygenation kinetics during cycle exercise. J Appl Physiol. 2007; 103,2049-2056
42. Vatner, SF; Pagani, M. Cardiovascular adjustments to exercise: Hemodynamics and mechanisms. Prog Cardiovasc Dis. 1976; 19,91-108.
43. Beckermann, BM; Kallifatidis, G; Groth, A; Frommhold, D; Apel, A; Mattern, J; Salnikov, AV; Moldenhauer, G; Wagner, W; Diehlmann, A; Saffrich, R; Schubert, M; Ho, AD; Giese, N; Büchler, MW; Friess, H; Büchler, P; Herr, I. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer. 2008 Jul 29. [Epub ahead of print]
44. Dias, S; Shmelkov, SV; Lam, G; Rafii, S. VEGF (165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood. 2002; 99(7),2532-2540
45. Baek, JH; Jang, JE; Kang, CM; Chung, HY; Kim, ND; Kim, KW. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene. 2000; 19(40),4621-4631
46. Tabernero, J. The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents. Mol Cancer Res. 2007; 5,203-220
47. Dor, Y; Porat, R; Keshet, E. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. Am J Physiol Cell Physiol. 2001; 280(6),C1367-74.
48. Recchia, F; Saggio, G; Di Blasio, A; Amiconi, G; Cesta, A; Candeloro, G; Alesse, E; Rea, S. Effect of interleukin-2 (IL-2) and 13-cis retinoic acid (RA) on vascular endothelial growth factor (VEGF) and durable response in patients with advanced solid tumors showing a partial response (PR) or stable disease (SD) to chemotherapy. J Clin Oncol. 2006; 24, 2521.
49. Colgan, SM; Mukherjee, S; Major, P. Hypoxia-induced lactate dehydrogenase expression and tumor angiogenesis. Clin Colorectal Cancer. 2007; 6,442-446
50. Adamski, JK; Estlin, EJ; Makin, GW. The cellular adaptations to hypoxia as novel therapeutic targets in childhood cancer. Cancer Treat Rev. 2008; 34,231-246
51. Lukacova, S; Sørensen, BS; Alsner, J; Overgaard, J; Horsman, MR. The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour models. Acta Oncol. 2008; 47,941-947
52. Leibovich, SJ; Chen, JF; Pinhal-Enfield, G; Belem, PC; Elson, G; Rosania, A; Ramanathan, M; Montesinos, C; Jacobson, M; Schwarzschild, MA; Fink, JS; Cronstein, B. Synergistic upregulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. Am J Pathol. 2002; 160(6),2231-2244
53. Wen, FQ; Liu, X; Manda, W; Terasaki, Y; Kobayashi, T; Abe, S; Fang, Q; Ertl, R; Manouilova, L; Rennard, SI. TH2 Cytokineenhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids. J Aller Clin Immunol. 2003; 111(6),1307-1318
54. Parajuli, P; Singh, SM. Alteration in IL-1 and arginase activity of tumor-associated macrophages: A role in the promotion of tumor growth. Cancer Lett. 1996; 107,249-256
55. Lim, KH; Ancrile, BB; Kashatus, DF; Counter, CM. Tumour maintenance is mediated by eNOS. Nature. 2008; 452,646-649
56. Saito, F; Matsusaka, S; Takahashi, Y; Wakabayashi, I. Enhancement of nitric oxide synthase induction in alveolar macrophages by in vivo administration of docetaxel. Eur J Pharmacol. 2008; 580,425-430